Loading...
Hologic, Inc.
HOLX•NASDAQ
HealthcareMedical - Instruments & Supplies
$64.33
$1.25(1.99%)
Hologic, Inc. (HOLX) Financial Performance & Statements
Review Hologic, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.00%
↓ 0.002%
Operating Income Growth
45.15%
↑ 45.15%
Net Income Growth
73.14%
↑ 73.14%
Operating Cash Flow Growth
22.26%
↑ 22.26%
Operating Margin
17.80%
↑ 17.80%
Gross Margin
51.75%
↑ 51.75%
Net Profit Margin
13.83%
↑ 13.83%
ROE
11.44%
↑ 11.44%
ROIC
9.49%
↑ 9.49%
Hologic, Inc. (HOLX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Hologic, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.02B | $987.90M | $1.01B | $1.02B |
| Cost of Revenue | $446.00M | $430.30M | $443.10M | $455.30M |
| Gross Profit | $575.80M | $557.60M | $568.30M | $562.50M |
| Gross Profit Ratio | $0.56 | $0.56 | $0.56 | $0.55 |
| R&D Expenses | $60.30M | $67.30M | $64.10M | $74.60M |
| SG&A Expenses | $281.80M | $249.20M | $240.30M | $244.60M |
| Operating Expenses | $350.70M | $327.60M | $304.40M | $319.20M |
| Total Costs & Expenses | $792.00M | $757.80M | $747.50M | $774.50M |
| Interest Income | $24.20M | $28.40M | $28.40M | $24.00M |
| Interest Expense | $30.50M | $31.90M | $31.90M | $32.30M |
| Depreciation & Amortization | $74.00M | $74.60M | $72.30M | $73.70M |
| EBITDA | $352.00M | $328.10M | $344.90M | $317.50M |
| EBITDA Ratio | $0.34 | $0.33 | $0.34 | $0.31 |
| Operating Income | $229.80M | $230.10M | $263.90M | $243.30M |
| Operating Income Ratio | $0.22 | $0.23 | $0.26 | $0.24 |
| Other Income/Expenses (Net) | $17.70M | -$8.50M | -$23.20M | -$31.80M |
| Income Before Tax | $247.50M | $221.60M | $240.70M | $211.50M |
| Income Before Tax Ratio | $0.24 | $0.22 | $0.24 | $0.21 |
| Income Tax Expense | $46.50M | $43.00M | $46.20M | $41.60M |
| Net Income | $201.00M | $178.60M | $194.50M | $169.90M |
| Net Income Ratio | $0.20 | $0.18 | $0.19 | $0.17 |
| EPS | $0.87 | $0.76 | $0.83 | $0.72 |
| Diluted EPS | $0.87 | $0.76 | $0.82 | $0.72 |
| Weighted Avg Shares Outstanding | $230.28M | $233.77M | $234.60M | $235.89M |
| Weighted Avg Shares Outstanding (Diluted) | $232.11M | $235.97M | $236.47M | $237.56M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan